The oncogenic Golgi phosphoprotein 3 like overexpression is associated with cisplatin resistance in ovarian carcinoma and activating the NF-κB signaling pathway

Global cancer statistics, 2012

(2015) Lindsey A. Torre et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Surgical technique ofen blocpelvic resection for advanced ovarian cancer

(2015) Suk-Joon Chang et al.   Journal of Gynecologic Oncology

Golgi phosphoprotein 3 (GOLPH3) promotes hepatocellular carcinoma cell aggressiveness by activating the NF-κB pathway

(2015) Ting Dai et al.   JOURNAL OF PATHOLOGY

Trends in Relative Survival for Ovarian Cancer From 1975 to 2011

(2015) Jason D. Wright et al.   OBSTETRICS AND GYNECOLOGY

A STAT3-NFkB/DDIT3/CEBPβ axis modulates ALDH1A3 expression in chemoresistant cell subpopulations

(2015) Claudia Canino et al.   Oncotarget

GOLPH3L is a Novel Prognostic Biomarker for Epithelial Ovarian Cancer

(2015) Yanling Feng et al.   Journal of Cancer

Impact of obesity on surgical and oncologic outcomes in ovarian cancer

(2014) Amanika Kumar et al.   GYNECOLOGIC ONCOLOGY

Ovarian Cancer

(2013) Pascale Amate et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER

The complexity of NF-κB signaling in inflammation and cancer

(2013) Bastian Hoesel et al.   Molecular Cancer

Trials Show Delayed Recurrence in Ovarian Cancer

(2013)   Cancer Discovery

Development and application of a DNA microarray-based yeast two-hybrid system

(2012) Bernhard Suter et al.   NUCLEIC ACIDS RESEARCH

Targeting NFĸB mediated breast cancer chemoresistance through selective inhibition of sphingosine kinase-2

(2011) James W. Antoon et al.   CANCER BIOLOGY & THERAPY

Inhibition of Aurora-A kinase induces cell cycle arrest in epithelial ovarian cancer stem cells by affecting NFĸB pathway

(2011) Ilana Chefetz et al.   CELL CYCLE